Klatser PR - Search Results

1

Elimination of leprosy and its consequences for research.

Faber WR, Klatser PR. Faber WR, et al. Among authors: klatser pr. Adv Exp Med Biol. 2003;531:295-7. doi: 10.1007/978-1-4615-0059-9_25. Adv Exp Med Biol. 2003. PMID: 12916801 Review. No abstract available.

2

Serum neopterin as a marker for reactional states in leprosy.

Hamerlinck FF, Klatser PR, Walsh DS, Bos JD, Walsh GP, Faber WR. Hamerlinck FF, et al. Among authors: klatser pr. FEMS Immunol Med Microbiol. 1999 Jul 15;24(4):405-9. doi: 10.1111/j.1574-695X.1999.tb01312.x. FEMS Immunol Med Microbiol. 1999. PMID: 10435759 Free article.

3

Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.

Verhagen C, Faber W, Klatser P, Buffing A, Naafs B, Das P. Verhagen C, et al. Am J Pathol. 1999 Jun;154(6):1793-804. doi: 10.1016/S0002-9440(10)65435-1. Am J Pathol. 1999. PMID: 10362804 Free PMC article.

4

Population survey to determine risk factors for Mycobacterium leprae transmission and infection.

Bakker MI, Hatta M, Kwenang A, Faber WR, van Beers SM, Klatser PR, Oskam L. Bakker MI, et al. Among authors: klatser pr. Int J Epidemiol. 2004 Dec;33(6):1329-36. doi: 10.1093/ije/dyh266. Epub 2004 Jul 15. Int J Epidemiol. 2004. PMID: 15256520

5

Risk factors for developing leprosy--a population-based cohort study in Indonesia.

Bakker MI, Hatta M, Kwenang A, Van Mosseveld P, Faber WR, Klatser PR, Oskam L. Bakker MI, et al. Among authors: klatser pr. Lepr Rev. 2006 Mar;77(1):48-61. Lepr Rev. 2006. PMID: 16715690

6

The relation between seroprevalence of antibodies against phenolic glycolipid-I among school children and leprosy endemicity in Brazil.

Bührer-Sékula S, van Beers S, Oskam L, Lecco R, Madeira ES, Dutra MA, Luis MC, Faber WR, Klatser PR. Bührer-Sékula S, et al. Among authors: klatser pr. Rev Soc Bras Med Trop. 2008;41 Suppl 2:81-8. doi: 10.1590/s0037-86822008000700017. Rev Soc Bras Med Trop. 2008. PMID: 19618082 Free article.

7

Follow-up of multibacillary leprosy patients using a phenolic glycolipid-I-based ELISA. Do increasing ELISA-values after discontinuation of treatment indicate relapse?

Chin-a-Lien RA, Faber WR, van Rens MM, Leiker DL, Naafs B, Klatser PR. Chin-a-Lien RA, et al. Among authors: klatser pr. Lepr Rev. 1992 Mar;63(1):21-7. doi: 10.5935/0305-7518.19920004. Lepr Rev. 1992. PMID: 1569812

8

[Serological diagnosis of leprosy].

Klatser PR, Naafs B, Faber WR. Klatser PR, et al. Ned Tijdschr Geneeskd. 1991 May 25;135(21):932-4. Ned Tijdschr Geneeskd. 1991. PMID: 2052109 Dutch. No abstract available.

9

Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients.

van der Vliet GM, Cho SN, Kampirapap K, van Leeuwen J, Schukkink RA, van Gemen B, Das PK, Faber WR, Walsh GP, Klatser PR. van der Vliet GM, et al. Among authors: klatser pr. Int J Lepr Other Mycobact Dis. 1996 Dec;64(4):396-403. Int J Lepr Other Mycobact Dis. 1996. PMID: 9030105

10

Use of ML dipstick as a tool to classify leprosy patients.

Buhrer-Sekula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JA, Vieira LM, de Matos HJ, Faber WR, Klatser PR. Buhrer-Sekula S, et al. Among authors: klatser pr. Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):456-63. Int J Lepr Other Mycobact Dis. 2000. PMID: 11332289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page